The Archive · 3 posts
Innovating healthcare! 🏥 CelLBxHealth PLC (CLBX) is pioneering cell therapy advancements on the LSE. Discover the future of medicine today! 🌟
CelLBxHealth's Q2 revenue doubled to £0.4 million, but lower first-half revenue and a £2.9 million cash balance keep funding risk central to the investment case.
July 15, 2026
Showing 2 of 3 posts
CelLBxHealth FY2025: revenue slumped to £1.4m, but cost cuts and partnerships with AstraZeneca, Roche, and QIAGEN aim for 50% growth in FY2026. High risk, strategic reset.
JoshuaJune 22, 2026
CellBxHealth signs Master Services Agreement with AstraZeneca for CTC-powered drug discovery-a major credibility boost, though financial impact remains undisclosed.
JoshuaMay 29, 2026